百度(09888.HK)成首批企業獲准在北京啟動自動駕駛前排無人測試
百度-SW(09888.HK)(BIDU.US)宣布,北京當局昨日(21日)發放自動駕駛無人化通知書,百度成為首批企業獲准正式在北京啟動自動駕駛前排無人測試,料將穩步推進自動駕駛全無人商業化進程。
公司表示,在當局一系列政策推動下,百度旗下自動駕駛出行服務平台蘿蔔快跑已組建國內最大的無人化自動駕駛車隊。
此次百度Apollo在北京市高級別自動駕駛示範區60平方公里範圍內,首批投入共10輛第五代無人車Apollo Moon,開展前排無人道路測試。
百度Apollo目前測試總里程超過3600萬公里,而蘿蔔快跑已在北京、重慶、武漢、長沙、合肥、陽泉等城市開展自動駕駛商業化出行服務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.